X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
silymarin (301) 301
humans (233) 233
index medicus (220) 220
animals (201) 201
male (191) 191
silymarin - pharmacology (161) 161
silymarin - therapeutic use (127) 127
female (121) 121
rats (115) 115
milk thistle (101) 101
oxidative stress (101) 101
pharmacology & pharmacy (101) 101
liver (96) 96
silibinin (93) 93
silymarin - administration & dosage (81) 81
mice (74) 74
liver - drug effects (72) 72
antioxidants (70) 70
middle aged (69) 69
antioxidants - pharmacology (68) 68
silymarin - adverse effects (64) 64
adult (59) 59
antioxidant (59) 59
antioxidants - therapeutic use (53) 53
health aspects (53) 53
care and treatment (51) 51
liver diseases (49) 49
phytotherapy (49) 49
apoptosis (47) 47
cancer (47) 47
research (47) 47
hepatotoxicity (46) 46
oxidative stress - drug effects (45) 45
liver - metabolism (44) 44
silybin (43) 43
treatment outcome (43) 43
oncology (42) 42
toxicology (42) 42
flavonoids (41) 41
biochemistry & molecular biology (40) 40
plant extracts - pharmacology (39) 39
rats, wistar (38) 38
analysis (37) 37
medicine (36) 36
protective agents - pharmacology (36) 36
aged (35) 35
prevention (35) 35
rodents (35) 35
plant extracts - therapeutic use (34) 34
chemical and drug induced liver injury - drug therapy (32) 32
gastroenterology & hepatology (32) 32
liver - pathology (32) 32
research article (32) 32
double-blind (31) 31
toxicity (31) 31
dose-response relationship, drug (30) 30
double-blind method (30) 30
integrative & complementary medicine (30) 30
milk thistle - chemistry (30) 30
protective agents - therapeutic use (30) 30
usage (30) 30
dietary supplements (29) 29
hepatitis (29) 29
silybum-marianum (29) 29
chemistry, medicinal (28) 28
inhibition (28) 28
apoptosis - drug effects (27) 27
enzymes (27) 27
nf-kappa-b (27) 27
pharmacology (27) 27
administration, oral (26) 26
chemical and drug induced liver injury - prevention & control (26) 26
expression (26) 26
rats, sprague-dawley (26) 26
bioavailability (25) 25
in-vitro (25) 25
inflammation (25) 25
alanine transaminase - blood (24) 24
bioflavonoids (24) 24
flavones (24) 24
lipid peroxidation (24) 24
metabolism (24) 24
antioxidants - administration & dosage (23) 23
disease models, animal (23) 23
lipid peroxidation - drug effects (23) 23
liver diseases - drug therapy (23) 23
clinical trials (22) 22
damage (22) 22
hepatitis c, chronic - drug therapy (22) 22
lipid-peroxidation (22) 22
liver-disease (22) 22
studies (22) 22
therapy (22) 22
ultraviolet rays - adverse effects (22) 22
article (21) 21
cells (21) 21
chemical and drug induced liver injury - metabolism (21) 21
pharmacokinetics (21) 21
plant sciences (21) 21
silymarin - chemistry (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (463) 463
Russian (10) 10
German (5) 5
Chinese (4) 4
Hungarian (3) 3
Italian (3) 3
Czech (2) 2
Persian (2) 2
Spanish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Phytotherapy Research, ISSN 0951-418X, 06/2019, Volume 33, Issue 6, pp. 1627 - 1638
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, p. e0147745
Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, has become one of the most common causes of chronic liver... 
3T3-L1 ADIPOCYTES | POPULATION | OBESITY | ACID | MULTIDISCIPLINARY SCIENCES | CURCUMA-LONGA | PPAR-GAMMA | ALPHA | STEATOHEPATITIS | HEPATIC STEATOSIS | BISDEMETHOXYCURCUMIN | Choline - metabolism | Non-alcoholic Fatty Liver Disease - pathology | Curcumin - analogs & derivatives | Cholesterol - blood | Liver | Body Weight - drug effects | Non-alcoholic Fatty Liver Disease - etiology | Male | Alanine Transaminase - blood | Protective Agents - pharmacology | Choline Deficiency - metabolism | Silymarin - pharmacology | Methionine - deficiency | Liver Function Tests | Mice, Inbred C57BL | Curcumin - pharmacology | Curcumin - isolation & purification | Food, Formulated - adverse effects | Non-alcoholic Fatty Liver Disease - metabolism | Protective Agents - isolation & purification | Choline Deficiency - pathology | Choline Deficiency - prevention & control | Drug Synergism | Organ Size - drug effects | Animals | Aspartate Aminotransferases - blood | Lipogenesis - drug effects | Non-alcoholic Fatty Liver Disease - prevention & control | Triglycerides - blood | Mice | Curcuma - chemistry | Turmeric | Complications and side effects | Fatty liver | Diet | Physiological aspects | Dosage and administration | Research | Drug therapy | Developed countries | Animal models | Body weight | Kinases | Synergism | Rodents | Polyphenols | Curcumin | Lipogenesis | Medical research | Obesity | Liver diseases | Methionine | Metabolic diseases | Pharmacology | Bioavailability | Gene expression | Chemical compounds | Steatosis | Polymerase chain reaction | Cirrhosis | Silymarin | Choline | Fibrosis | Synergistic effect | Metabolic disorders
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 11/2016, Volume 29, Issue 3, pp. 289 - 296
AIMThe utility of noninvasive serum markers to longitudinally monitor liver fibrosis is not established. METHODSA total of 70 patients with chronic hepatitis C... 
silymarin | histology | chronic hepatitis C | fibrosis | biomarker | interferon | longitudinal | UNITED-STATES | TESTS | CHRONIC HEPATITIS-C | BIOPSY | ELASTOGRAPHY | ACCURACY | CIRRHOSIS | VALIDATED PREDICTOR | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Liver - virology | Recombinant Proteins - therapeutic use | Predictive Value of Tests | Liver - pathology | Prospective Studies | Humans | Middle Aged | Hepacivirus - genetics | Male | Polyethylene Glycols - therapeutic use | Viral Load | Young Adult | Austria | Liver - drug effects | Time Factors | Hyaluronic Acid - blood | Antiviral Agents - therapeutic use | Liver - metabolism | Genotype | Liver Cirrhosis - blood | Procollagen - blood | Biomarkers - blood | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Antiviral Agents - adverse effects | Adolescent | Germany | Area Under Curve | Polyethylene Glycols - adverse effects | RNA, Viral - blood | Recombinant Proteins - adverse effects | Peptide Fragments - blood | Adult | Female | Drug Therapy, Combination | Tissue Inhibitor of Metalloproteinase-1 - blood | Hepacivirus - drug effects | Liver Cirrhosis - drug therapy | Silymarin - therapeutic use | Liver Cirrhosis - diagnosis | Silymarin - adverse effects | Interferon-alpha - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - blood | Liver Cirrhosis - virology | Biopsy | ROC Curve | Aged | Interferon-alpha - adverse effects
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2011, Volume 650, Issue 1, pp. 335 - 341
Journal Article
Angiology, ISSN 0003-3197, 10/2015, Volume 66, Issue 9, pp. 856 - 861
Journal Article
Gastroenterology and hepatology from bed to bench, ISSN 2008-2258, 2019, Volume 12, Issue 2, pp. 138 - 142
This study was performed to evaluate the potential efficacy of silymarin in the management of anti-tuberculosis medication's induced liver injury. Hepatic... 
Drug induced hepatitis | Tuberculosis | Adverse effects | Silymarin | Original
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 12/2013, Volume 384, Issue 1, pp. 47 - 58
Journal Article
Journal Article